What are the top competitors of CBHD.DE in Healthcare sector?

The top competitors of CBHD.DE in the Healthcare sector are: Henry Schein, Inc. (HS2.DE), DENTSPLY SIRONA Inc. (DY2.DE).

Which has better valuations & earnings, CBHD.DE or its competitors?

CBHD.DE has a market cap of 19.29B and a Dividend Yield of 1.68% compared to its competitors.

Which stock is more profitable: CBHD.DE or its competitors?

CBHD.DE has an EPS of $2.70, while HS2.DE has an EPS of $3.23. So, CBHD.DE is more profitable compared to HS2.DE.

What is CBHD.DE stock volatility and risk in terms of investment?

CBHD.DE has daily volatility of 1.48% as compared to its competitor HS2.DE which is 0.03%. CBHD.DE is more volatile as compared to competitors and has high risk.

Is CBHD.DE stock profitable?

CBHD.DE has a Return on Equity (ROE) of 0.30%. So, CBHD.DE is more profitable.

What is CBHD.DE stock’s 52 weeks high and low?

CBHD.DE stock has a 52-week high of ($128) and a low of ($84.5).

What was the average volume of CBHD.DE stock?

The average volume of CBHD.DE is (357.00) in terms of investment.

Coloplast A/S (CBHD.DE) Competitors

Coloplast A/S CBHD.DE Peers

See (CBHD.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Equipment & Services Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
CBHD.DE	$85.12	-1.78%	19.29B	31.53	$2.70	+1.68%
HS2.DE	$74.06	+0.11%	9.38B	22.93	$3.23	N/A
DY2.DE	$17.77	+0.54%	3.76B	8.34	$2.13	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CBHD.DE vs HS2.DE Comparison

CBHD.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CBHD.DE stands at 19.29B. In comparison, HS2.DE has a market cap of 9.38B. Regarding current trading prices, CBHD.DE is priced at $85.12, while HS2.DE trades at $74.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CBHD.DE currently has a P/E ratio of 31.53, whereas HS2.DE's P/E ratio is 22.93. In terms of profitability, CBHD.DE's ROE is +0.30%, compared to HS2.DE's ROE of +0.11%. Regarding short-term risk, CBHD.DE is more volatile compared to HS2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for CBHD.DE.

Coloplast A/S